Literature DB >> 26706401

Clinical manifestations in uveitis patients with and without rheumatic disease in a Chinese population in Taiwan.

Shi-Ting Tseng1, Tsung-Chieh Yao2, Jing-Long Huang2, Kuo-Wei Yeh3, Yih-Shiou Hwang4.   

Abstract

BACKGROUND/
PURPOSE: Uveitis can be a local eye disease or a manifestation of systemic rheumatologic disorders. However, the differences of clinical manifestations between uveitis patients with or without systemic rheumatologic disease have been seldom described in literature. We investigated the clinical features and complications of rheumatic disease-related uveitis, and compared the characteristics in patients with and without rheumatic disease in a Chinese population in Taiwan.
METHODS: A retrospective review was performed for all patients who had been diagnosed with uveitis between January 2009 and June 2014 at the Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
RESULTS: A total of 823 uveitis patients were enrolled in the study, including 123 patients with rheumatic diseases. The most frequent rheumatic diseases included ankylosing spondylitis (5.8%), followed by Behçet's disease (2.8%), sarcoidosis (1.4%), psoriasis (1.1%), and juvenile idiopathic arthritis (1.1%). Compared with patients without rheumatic disease, those with rheumatic disease-related uveitis had a lower mean age at onset (35.1 ± 15.8 years vs. 44.0 ± 17.5 years), a longer follow-up period (27.1 ± 25.3 months vs. 22.2 ± 23.0 months), a higher incidence of anterior uveitis (69.0% vs. 46.3%), less frequent posterior uveitis (4.9% vs. 21.4%), a higher incidence of recurrence (26.8% vs. 14.1%), more frequent bilateral involvement (53.7% vs. 38.8%), and more frequent posterior synechiae (17.2% vs. 9.4%).
CONCLUSION: The disease course and clinical manifestations of rheumatic disease-related uveitis were different from those unrelated. Patients with rheumatic disease-related uveitis had a higher recurrent rate and more frequent posterior synechiae than patients without rheumatic diseases.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  autoimmune disease; epidemiology; rheumatic disease; uveitis

Mesh:

Year:  2015        PMID: 26706401     DOI: 10.1016/j.jmii.2015.10.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  The incidence, risk factor, and time to develop rheumatologic diseases after isolated inflammatory eye diseases: a 12-year cohort study.

Authors:  Kittiwan Sumethkul; Indhira Urailert; Tassanee Kitumnuaypong; Sungchai Angthararak; Sukhum Silpa-Archa
Journal:  Clin Rheumatol       Date:  2022-01-10       Impact factor: 2.980

2.  Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.

Authors:  Ana M Roldan; Nazlee Zebardast; Maxwell Pistilli; Naira Khachatryan; Abhishek Payal; Hosne Begum; Pichaporn Artornsombudh; Siddharth S Pujari; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Jeanine M Buchanich; John H Kempen
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.258

Review 3.  Noninfectious uveitis in the Asia-Pacific region.

Authors:  Yung-Ray Hsu; Jerry Chien-Chieh Huang; Shih-Hwa Chiou; De-Kuang Hwang; Yong Tao; Toshikatsu Kaburaki; Christopher Seungkyu Lee; Tai-Chi Lin; Chih-Chien Hsu
Journal:  Eye (Lond)       Date:  2018-10-15       Impact factor: 3.775

4.  Development of Kaempferol-Loaded Gelatin Nanoparticles for the Treatment of Corneal Neovascularization in Mice.

Authors:  Yu-Lun Chuang; Hsu-Wei Fang; Aditya Ajitsaria; Ko-Hua Chen; Chen-Ying Su; Guei-Sheung Liu; Ching-Li Tseng
Journal:  Pharmaceutics       Date:  2019-11-28       Impact factor: 6.321

5.  The Association with rhegmatogenous retinal detachment and paediatric atopic dermatitis: a 12-year Nationwide Cohort Study.

Authors:  M Choi; S J Byun; D H Lee; K H Kim; K H Park; S J Park
Journal:  Eye (Lond)       Date:  2020-02-20       Impact factor: 3.775

6.  Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice.

Authors:  Sheng-Min Hsu; Chang-Hao Yang; Hsien-Yang Tsai; Chia-Jhen Lin; Yi-Hsuan Fang; Chi-Chang Shieh; Shun-Hua Chen
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

Review 7.  Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update.

Authors:  Elvis Hysa; Carlo Alberto Cutolo; Emanuele Gotelli; Greta Pacini; Carlotta Schenone; Elke O Kreps; Vanessa Smith; Maurizio Cutolo
Journal:  Eur J Clin Invest       Date:  2021-05-05       Impact factor: 4.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.